Intra-day change in occurrence of out-of-hospital ventricular fibrillation in Japan: The JCS-ReSS study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 Nov 2020
Historique:
received: 05 02 2020
revised: 17 05 2020
accepted: 10 06 2020
pubmed: 23 6 2020
medline: 15 5 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Real-world evidence of out-of-hospital ventricular fibrillation (VF), especially regarding intra-day change, remains unclear. We aimed to investigate that age- and gender-dependent difference of intra-day change of VF occurrence. We enrolled 71,692 patients (males: 56,419 [78.7%], females: 15,273 [21.3%]) in whom cardiac VF had been documented from the 2005-2015 All-Japan Utstein Registry data. Subjects were divided into four groups: group-I (<18 years old), group-II (18-39), group-III (40-69), and group-IV (≥70). Among four groups in each of male and female, we compared the intra-day change of VF occurrence, and evaluated the risk factors of the unfavorable neurologic outcomes at 1 month after VF. Regardless of age, the incidence of VF was significantly greater in male than in female subjects. In male subjects, VF in group-I, III and IV occurred higher at daytime, however, group-II had no intra-day difference because group-II had a higher VF events at midnight~ early morning compared with other aged groups (Poisson regression analysis, p = .03). While in female, each group showed similar intra-day pattern of VF occurrence. Logistic regression analysis revealed that some of the clinical parameters such as time periods from call receipt to first shock and the presence of bystander cardiopulmonary resuscitation were important for risk of 30-day neurologically unfavorable outcomes. The intra-day change of VF occurrence was age-dependently different in males but not in females, suggesting age- and gender-dependent differences in underlying cardiac diseases. These might affect the significant difference in unfavorable neurologic outcome.

Sections du résumé

BACKGROUND BACKGROUND
Real-world evidence of out-of-hospital ventricular fibrillation (VF), especially regarding intra-day change, remains unclear. We aimed to investigate that age- and gender-dependent difference of intra-day change of VF occurrence.
METHOD METHODS
We enrolled 71,692 patients (males: 56,419 [78.7%], females: 15,273 [21.3%]) in whom cardiac VF had been documented from the 2005-2015 All-Japan Utstein Registry data. Subjects were divided into four groups: group-I (<18 years old), group-II (18-39), group-III (40-69), and group-IV (≥70). Among four groups in each of male and female, we compared the intra-day change of VF occurrence, and evaluated the risk factors of the unfavorable neurologic outcomes at 1 month after VF.
RESULTS RESULTS
Regardless of age, the incidence of VF was significantly greater in male than in female subjects. In male subjects, VF in group-I, III and IV occurred higher at daytime, however, group-II had no intra-day difference because group-II had a higher VF events at midnight~ early morning compared with other aged groups (Poisson regression analysis, p = .03). While in female, each group showed similar intra-day pattern of VF occurrence. Logistic regression analysis revealed that some of the clinical parameters such as time periods from call receipt to first shock and the presence of bystander cardiopulmonary resuscitation were important for risk of 30-day neurologically unfavorable outcomes.
CONCLUSIONS CONCLUSIONS
The intra-day change of VF occurrence was age-dependently different in males but not in females, suggesting age- and gender-dependent differences in underlying cardiac diseases. These might affect the significant difference in unfavorable neurologic outcome.

Identifiants

pubmed: 32569698
pii: S0167-5273(20)33392-1
doi: 10.1016/j.ijcard.2020.06.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-60

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Aiba reported being affiliated with the endowed department by Japan Medtronic Inc.

Auteurs

Sou Otsuki (S)

National Cerebral and Cardiovascular Center, Suita, Japan; Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan.

Takeshi Aiba (T)

National Cerebral and Cardiovascular Center, Suita, Japan. Electronic address: aiba@ncvc.go.jp.

Yoshio Tahara (Y)

National Cerebral and Cardiovascular Center, Suita, Japan.

Kenzaburo Nakajima (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Naoya Kataoka (N)

National Cerebral and Cardiovascular Center, Suita, Japan.

Tsukasa Kamakura (T)

National Cerebral and Cardiovascular Center, Suita, Japan.

Mitsuru Wada (M)

National Cerebral and Cardiovascular Center, Suita, Japan.

Kohei Ishibashi (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Kenichiro Yamagata (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Yuko Inoue (Y)

National Cerebral and Cardiovascular Center, Suita, Japan.

Koji Miyamoto (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Satoshi Nagase (S)

National Cerebral and Cardiovascular Center, Suita, Japan.

Takashi Noda (T)

National Cerebral and Cardiovascular Center, Suita, Japan.

Chisato Izumi (C)

National Cerebral and Cardiovascular Center, Suita, Japan.

Teruo Noguchi (T)

National Cerebral and Cardiovascular Center, Suita, Japan.

Kunihiro Nishimura (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Naohiro Yonemoto (N)

Juntendo University Graduate School of Medicine, Tokyo, Japan.

Hiroshi Nonogi (H)

Shizuoka General Hospital, Shizuoka, Japan.

Ken Nagao (K)

Nihon University, Tokyo, Japan.

Takanori Ikeda (T)

Toho University, Tokyo, Japan.

Naoki Sato (N)

Nippon Medical School, Tokyo, Japan.

Hiroyuki Tsutsui (H)

Kyushu University, Fukuoka, Japan.

Satoshi Yasuda (S)

National Cerebral and Cardiovascular Center, Suita, Japan.

Kengo Kusano (K)

National Cerebral and Cardiovascular Center, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH